EDGAR Filing Documents for 0001104659-15-069113

Form 8-K - Current report:

SEC Accession No. 0001104659-15-069113

Filing Date

2015-10-05

Accepted

2015-10-05 16:20:52

Documents

Period of Report

2015-09-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-20769_18k.htm	8-K	32246
2	EX-10.1	a15-20769_1ex10d1.htm	EX-10.1	25046
	Complete submission text file	0001104659-15-069113.txt		58764

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940

Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681

Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)